Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Baricitinib effectively reduces hair loss in severe alopecia areata and is generally safe.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Cyclosporine effectively treated a woman's stubborn skin condition.

A 10-year-old boy recovered from a scalp infection caused by a fungus after treatment with itraconazole.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

The new microneedle patch effectively treats alopecia areata with fewer side effects than oral medication.

GRF is not safe for tubal occlusion.

Dupilumab for eczema may cause hair loss.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Using topical prostaglandin F2α for glaucoma may cause loss of eyelash or eyebrow pigment.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Certain probiotics can help improve skin conditions like atopic dermatitis, but more research is needed.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

The gel shows strong potential for effectively treating pressure ulcers.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Allopurinol may cause rare granulomatous microscopic colitis.

Tofacitinib helps mice grow more hair by increasing noggin and BMP4 levels, possibly better than minoxidil.

GHK-Cu liposome promotes hair growth in mice with alopecia.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.